Experts warn increasing IDUs in eastern, southern Africa could threaten HIV/AIDS fight

NewsGuard 100/100 Score

An increase in the number of injection drug users (IDUs) in eastern and southern Africa stands to harm efforts to control the spread of HIV/AIDS in the region, warned experts gathered at the World Forum Against Drug conference in Sweden on Monday, Agence France-Presse reports.

"I think one of our largest concerns in Kenya is the large number of people who are addicted to heroin, and many of them are actually injecting themselves," Jennifer Kimani of Kenya's National Campaign Against Drug Abuse said during the conference. "Among the injecting drug users, 68 to 88 percent are HIV positive," she added.

Olawale Maiyegun, the head of the African Union's Social Affairs Department, reiterated the concern expressed by Kimani. "It is feared that the next round of an HIV/AIDS epidemic might be (prompted) by drug injection," Maiyegun said, appealing for increased efforts to understand the scope drug use in the region.

A 2008 report from the U.N.'s Narcotics Control Board indicated that "East Africa has become 'the major conduit for smuggling heroin from southwest Asia into Africa (and on to) Europe and North America," AFP writes. "The abuse of heroin has become a matter of concern in some east and southern African countries," the report added (5/24).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk